Comparing two heart rate medicines for clozapine users
Treatments studied
Part of Heart & circulation, Mental health clinical trials.
This study compares two medications (atenolol and ivabradine) to see which one better controls a fast heart rate (tachycardia) in people with treatment-resistant schizophrenia who are taking clozapine. The goal is to find a safer way to manage this side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have treatment-resistant schizophrenia and are currently taking clozapine.
- Your resting heart rate is above 100 beats per minute.
- You are not already taking atenolol or ivabradine.
- You do not have any serious medical or neurological condition that would make these treatments unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different medicines to slow a rapid heartbeat caused by atrial fibrillation or flutter. You will receive either an oral pill (bisoprolol) or intravenous (IV) medication (diltiazem) to see which works better and faster.
This trial compares two common heart medicines (verapamil and metoprolol) to see which works better for people with a fast, irregular heartbeat called atrial fibrillation. If you come to the Emergency Department with a heart rate of 110 or more and are stable, you may be able to join.
This study compares two heart-rate medicines—propranolol and ivabradine—to see which better improves symptoms in people with POTS. It uses a “crossover” design, meaning you may try one medicine and then switch to the other.
This trial tests two medicines to lower heart rate before a cardiac CT scan in adults who need the scan. It is for people whose heart rate is naturally a bit fast (over 65 beats per minute) but not too fast (under 100 bpm).
This trial tests whether a target heart rate (below 80 beats per minute) is better than a more lenient one for people with persistent or permanent atrial fibrillation. It aims to find the best way to control your heart rate and improve your quality of life.
This trial tests a medication called ivabradine that may lower your heart rate during exercise. It is studying healthy adults to see how the medicine affects heart rate while you are active.
Hear when a new Treatment Resistant Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.